Pharmaceuticals and antibiotics co-occur in the aquatic environment but mixture studies to date 37 have mainly focused on pharmaceuticals alone or antibiotics alone, although differences in mode of 38 action may lead to different effects in mixtures. In this study we used the Bacterial Luminescence 39 Toxicity Screen (BLT-Screen) after acute (0.5 h) and chronic (16 h) exposure to evaluate how non-40 specifically acting pharmaceuticals and specifically acting antibiotics act together in mixtures. 41 Three models were applied to predict mixture toxicity including concentration addition, 42 independent action and the two-step prediction (TSP) model, which groups similarly acting 43 chemicals together using concentration addition, followed by independent action to combine the 44 two groups. All non-antibiotic pharmaceuticals had similar EC 50 values at both 0.5 and 16 h, 45 indicating together with a QSAR (Quantitative Structure-Activity Relationship) analysis that they 46 act as baseline toxicants. In contrast, the antibiotics' EC 50 values decreased by up to three orders of 47 magnitude after 16 h, which can be explained by their specific effect on bacteria. Equipotent 48 mixtures of non-antibiotic pharmaceuticals only, antibiotics only and both non-antibiotic 49 pharmaceuticals and antibiotics were prepared based on the single chemical results. The mixture 50 toxicity models were all in close agreement with the experimental results, with predicted EC 50 51 values within a factor of two of the experimental results. This suggests that concentration addition 52 can be applied to bacterial assays to model the mixture effects of environmental samples containing 53
Introduction 60
Bacterial assays based on bioluminescence inhibition are widely applied tools to evaluate the effect 61 of individual chemicals, chemical mixtures and environmental samples (Altenburger et al., 2000 ; 62 Katsoyiannis and Samara, 2007; Escher et al., 2008; Tang et al., 2013) . The advantages of such 63 assays include ease of use, sensitivity and speed, with sample exposure times typically between 15 64 to 30 minutes (Parvez et al., 2006) . Further, Kaiser (1998) found a good correlation between a range 65 of aquatic in vivo endpoints and observed effect in marine bacteria Aliivibrio fischeri, more 66 commonly referred to as the Microtox assay. While acute bacterial assays are suitable for non-67 specifically acting compounds, their applicability to specifically acting chemicals, such as 68 antibiotics, is questionable, with several studies finding low or no effect in the Microtox assay after 69 exposure to different classes of antibiotics (Isidori et Consequently, it is important to consider the potential mixture effects that can occur between 81 chemicals. Mixtures that contain chemicals that share a common mode of action in a particular 82 organism can be predicted using the concentration addition model, while chemicals that act 83 according to different modes of action can be described by independent action (Backhaus and Faust, 84 2012). While environmental samples typically contain a large number of chemicals with diverse 85 modes of action, the concentration addition model is considered to be suitable for hazard 86 assessment as it provides a worst-case prediction of mixture toxicity in most cases (Backhaus et al., 87 2000) . An alternative approach is the two-step prediction (TSP) model proposed by Junghans 88 (2004) , which groups similarly acting compounds together using the concentration addition model 89 and then applies independent action to combine the predicted effects of the individual groups. This 90 has previously been applied to successfully predict mixture toxicity in Daphnia magna (Ra et al., 91 2006 ) and algal assays (Tang and Escher, 2014). 92
In this study the Bacterial Luminescence Toxicity Screen (BLT-Screen) using bioluminescent 94 bacteria Photobacterium leiognathi was applied to single compounds and mixtures containing both 95 non-specifically acting pharmaceuticals, referred to as non-antibiotic pharmaceuticals, and 96 specifically acting antibiotics after both acute and chronic exposure. Backhaus et al. (1997) showed 97 that the ratio of acute to chronic effects in bioluminescent bacteria can provide information about 98 the mode of action of studied chemicals, with an increased acute to chronic ratio observed for 99 specifically acting chemicals. In the current study 0.5 h was used for acute exposure as this is the 100 typical sample exposure period in the assay (van de Merwe Five non-antibiotic pharmaceuticals, carbamazepine, diclofenac, fluoxetine, gemfibrozil and 113 naproxen, and five antibiotics, doxycycline, monensin, sulfamethizole, sulfamethoxazole and 114 tetracycline, were selected for this study. Properties of the studied chemicals are provided in Table  115 1. Pentachlorophenol (PCP) was used as the positive reference compound for the BLT-Screen. PCP 116 is an weak acid uncoupler and exhibits a specific effect in the assay (Schultz and Cronin, 1997). 117
Individual chemical stocks and chemical mixtures were prepared in HPLC grade methanol. All 118 chemicals were purchased from Sigma Aldrich (Castle Hill, Australia) or Novachem Pty Ltd 119 (Collingwood, Australia). 120 121
Bioanalysis 122
The BLT-Screen was run according to van de Merwe and Leusch (2015), with some modifications. 123
Briefly, the chemical stocks, along with positive control PCP and solvent control methanol, were 124 added to white 96 well plates and serially diluted in phosphate buffer (pH 4) using either a 1:3 or 125 1:5 dilution series, with a final volume of 200 µL. The final concentration of methanol in the assay 126 did not exceed 0.8% (v/v). While many bacterial assays are conducted at pH 7, the BLT-Screen was Following the serial dilution, a cryopreserved Photobacterium leiognathi stock was thawed and 129 diluted 1:6 in growth medium, with 5 µL of growth medium added to each well. Luminescence was 130 measured at 0.5 and 16 h using a Fluostar Omega plate reader (BMG Labtech, Ortenberg, 131 Germany). Between readings, the plates were stored at 22°C and gently shaken at 90 RPM. Percent 132 luminescence inhibition was calculated using Equation 1 based on sample luminescence, provided 133 in relative light units (RLU), (RLU sample ) and the average luminescence of the solvent control 134 (RLU control ). All samples were run in duplicate on the same plate, with each sample run 135 independently two to three times. RLU control was reasonably stable between experiments (coefficient 136 of variance <20%), with RLU control typically decreasing by approximately 35% from 0.5 to 16 h. 137
The effect concentration causing 50% effect (EC 50 ) at 0.5 and 16 h was calculated using log-logistic 138 concentration-effect curves (Equation 2), where EC i is the concentration at a defined percent effect 139 y. The slope was fitted from the experimental data. 140 
The variability associated with the mixture toxicity model predictions was estimated using error 161 
The CA prediction was calculated for a range of effect levels y to draw a complete concentration-189 effect curve for CA, while the IA prediction was calculated for a range of concentrations C to draw 190 a complete concentration-effect curve for IA. For the ten-component mixtures, the TSP model was 191 also applied by predicting concentration addition for the non-antibiotic pharmaceutical group and 192 antibiotics group separately and then combining the two groups together using the independent 193 action model. 194 (Table 3 ). The ratio of EC 50 at 0.5 h to EC 50 at 16 h ranged from 7.2 to 995. 206
The two most potent antibiotics, doxycycline and tetracycline, inhibit protein synthesis, and 207 previous studies also found that this class of antibiotics were among the most toxic to Aliivibrio the QSAR to account for speciation (Table 1) . Therefore, while the QSAR was developed based on 229 the experimental K lipw of neutral compounds, D lipw could be applied to correct for speciation at pH 230 4. Figure 3 indicates that the majority of non-antibiotic pharmaceuticals fit well with the QSAR 231 predictions based on the Microtox assay, with the ratio of the QSAR predicted EC 50 to the 232 experimental EC 50 , also known as the toxic ratio, less than 10, suggesting that the non-antibiotic 233 pharmaceuticals are baseline toxicants (Tang et al., 2013). The exception was naproxen, which had 234 a toxic ratio from 70 (0.5 h) to 250 (16 h). While a toxic ratio above 10 usually indicates that a suggests that it is having a non-specific effect on Photobacterium leiognathi. Thus, the dissimilarity 237 may be related to differences in sensitivity of the applied bacterial strain (Aliivibrio fischeri 238 compared to Photobacterium leiognathi). van de Merwe and Leusch (2015) also found a similar 239 EC 50 value for naproxen in the BLT-Screen (Figure 3) . In contrast, all antibiotics at both 0.5 and 16 240 h deviated significantly from the baseline toxicity QSAR, which was also observed by Tang et al. (Table 4 ). Concentration addition was more conservative than independent action for the 247 non-antibiotic pharmaceutical-only mixtures at both 0.5 and 16 h, with the concentration addition 248 predicted concentration-effect curves agreeing well with the experimental results ( Figure 4A-B) . 249
However, the independent action EC 50 predictions were only a factor of two higher than the 250 experimental EC 50 values. For the antibiotics, independent action yielded a lower EC 50 at 0.5 h 251 ( Figure 4C This was possible as the ratio of similarly acting components within each group remained the same 267 in both the five and ten-component mixtures. All three models gave a good agreement with the 268 experimental data, with all predictions within a factor of two of the experimental EC 50 values. The 269 specific chemicals in bioluminescent bacterial assays. However, given the similarity of all 272 predictions, this still supports the application of concentration addition as a suitable model for 273 compounds whose mode of action is unknown, given it tends to be more conservative, particularly 274 at the chronic 16 h exposure. This suggests that the bioanalytical equivalent approach, which 275 assumes that chemicals act according to concentration addition (Neale et al., 2015) , can be applied 276 to predict the mixture toxicity of environmental samples containing both antibiotics and non-277 specifically acting chemicals in bacterial assays. 278 279
Conclusions 280
In this study the effect of two groups of commonly detected water pollutants, pharmaceuticals and 281 antibiotics, were assessed in the BLT-Screen after acute (0.5 h) and chronic (16 h) exposure 282 periods, with equipotent mixtures prepared. Despite using a different bacterial species, the EC 50 283 values for most non-antibiotic pharmaceuticals fit well with previously published baseline toxicity 284 QSAR predictions; however, the QSAR was clearly unsuitable for specifically acting antibiotics, 285
with the observed effect two to seven orders of magnitude higher than predicted. Thus, while the 286 bioluminescence inhibition of bacteria is widely applied to test the baseline toxicity of chemical and 287 
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*D lipw measured at pH 7, but fluoxetine speciation is fully charged at pH 4 and 7. 
